Search research articles
Contact Us
Filters
Showing results (61-70 of 270) with videos related to
Page
of 27
Sort By:
Functional Neurology
|
July 1, 1987
Somatosensory-evoked potentials (SEPs) are affected differently by mu- and kappa-selective opioids in the dog
E Freye, R Buhl, G K Schenk
Respiratory Medicine
|
February 23, 2002
The whole story: treatment outcomes with Symbicort
Zetterström, R Buhl, H Mellem, et al.
Pneumologie (Stuttgart, Germany)
|
August 5, 2004
[Seasonal variations of serum-IgE and potential impact on dose-calculation of omalizumab (rhuMab-E25, anti-IgE)]
K M Beeh, J Beier, R Buhl
European Journal of Nutrition
|
May 7, 2002
Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients
P Micke, K M Beeh, R Buhl
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
June 1, 1994
In vivo assessment of pulmonary oxidant damage: the role of bronchoalveolar lavage
R Buhl, E Stahl, J Meier-Sydow
Medizinische Klinik (Munich, Germany : 1983)
|
November 25, 2000
[Anticholinergic drugs in therapy of chronic obstructive lung disease (COPD)]
K M Beeh, T Welte, R Buhl
The European Respiratory Journal
|
December 6, 2000
Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals
K M Beeh, M Ksoll, R Buhl
Pneumologie (Stuttgart, Germany)
|
May 5, 1999
[Gene therapy in cancers of the lung and pleura]
R Wiewrodt, M Schuler, C Huber, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 1, 1995
Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals
A Meyer, R Buhl, S Kampf, et al.
Pneumologie (Stuttgart, Germany)
|
November 1, 1995
[Therapy of cystic fibrosis in adulthood--current and future management]
J Bargon, S Sanders, W Caspary, et al.
Page
of 27
Search research articles
Search
Showing results (61-70 of 270) with videos related to
Sort By:
Page
of 27
Functional Neurology
|
July 1, 1987
Somatosensory-evoked potentials (SEPs) are affected differently by mu- and kappa-selective opioids in the dog
E Freye, R Buhl, G K Schenk
Respiratory Medicine
|
February 23, 2002
The whole story: treatment outcomes with Symbicort
Zetterström, R Buhl, H Mellem, et al.
Pneumologie (Stuttgart, Germany)
|
August 5, 2004
[Seasonal variations of serum-IgE and potential impact on dose-calculation of omalizumab (rhuMab-E25, anti-IgE)]
K M Beeh, J Beier, R Buhl
European Journal of Nutrition
|
May 7, 2002
Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients
P Micke, K M Beeh, R Buhl
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
June 1, 1994
In vivo assessment of pulmonary oxidant damage: the role of bronchoalveolar lavage
R Buhl, E Stahl, J Meier-Sydow
Medizinische Klinik (Munich, Germany : 1983)
|
November 25, 2000
[Anticholinergic drugs in therapy of chronic obstructive lung disease (COPD)]
K M Beeh, T Welte, R Buhl
The European Respiratory Journal
|
December 6, 2000
Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals
K M Beeh, M Ksoll, R Buhl
Pneumologie (Stuttgart, Germany)
|
May 5, 1999
[Gene therapy in cancers of the lung and pleura]
R Wiewrodt, M Schuler, C Huber, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 1, 1995
Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals
A Meyer, R Buhl, S Kampf, et al.
Pneumologie (Stuttgart, Germany)
|
November 1, 1995
[Therapy of cystic fibrosis in adulthood--current and future management]
J Bargon, S Sanders, W Caspary, et al.
Page
of 27